When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Acorda Therapeutics (ACOR) recently reported a huge earnings beat in both earnings per share “EPS” and revenue. The company beat in Non-GAAP EPS of -$0.55 (beats by $0.51) and a GAAP EPS of -$0.58 (beats by $0.68), with revenue coming in at $50.05M which was a $21.22M beat. Typically, when a company records twice the estimated revenue, the stock usually has a positive reaction. However, ACOR got completely decimated under high trading volume the following trading day and dropped over 50% to a new 52-week low of $2.87 per share.